von Willebrand factor elevates plasma factor VIII without induction of factor VIII messenger RNA in the liver

Blood

Volumn 93, Issue 1, 1999, Pages 193-197

  Kaufman, Randal J ^a   Dorner, Andrew J ^b   Fass, David N ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; MESSENGER RNA; RISTOCETIN; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CHO CELL; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENE THERAPY; HELA CELL; HEMOPHILIA A; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LIVER BIOPSY; NONHUMAN; PRIORITY JOURNAL; RIBONUCLEASE PROTECTION ASSAY; SWINE; TRANSCRIPTION REGULATION;

EID: 0032960838     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.1.193     Document Type: Article

References (59)

1. Toole JJ, Knopf JL, Wozney JM, Suitzman LA, Buecker JL, Pittman DD, Kaufman RJ, Brown E, Shoemaker C, Orr EC, Amphlett GW, Foster WB, Coe, ML, Knutson, GJ, Fass DN, Hewick RM: Molecular cloning of a cDNA encoding human antihaemophilic factor. Nature 312:342, 1984
2. Vehar GA, Keyt B, Eaton D, Rodriguez H, O'Brien DP, Rotblat F, Oppermann H, Keck R, Wood WI, Harkins RN, Tuddenham EGD, Lawn RM, Capon DJ: Structure of human factor VIII. Nature 312:337, 1984
3. Tuddenham EGD, Lane RS, Rotblat F, Johnson AJ, Snape TJ, Middleton S, Kernoff PB: Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human hemophilia A and von Willebrand's disease. Br J Haematol 52:259, 1982
4. Douglas AS: Antihemophilic globulin assay following plasma infusions in hemophilia. J Lab Clin Med 51:850, 1958.
5. Over J, Sixma JJ, Bruine MH, Trieschnigg MC, Vlooswijk RA, Beeser-Visser NH, Bouma, B.N: Survival of 125 iodine-labeled factor VIII in normals and patients with classic hemophilia. Observations on the heterogeneity of human factor VIII. J Clin Invest 62:223, 1978
6. Brinkhous KM, Sandberg H, Garris JB, Mattsson C, Palm M, Griggs T, Read MS: Purified human factor VIII procoagulant protein: Comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs. Proc Natl Acad Sci USA 82:8752, 1985
7. Weiss HJ, Sussman II, Hoyer LW: Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease. J Clin Invest 60:390, 1977
8. Fass DN, Bowie, EJW, Owen CA, Mann KG: Stability of porcine factor VIII. Thromb Res 6:109, 1975
9. Hamer RJ, Koedam JA, Beeser-Visser NH, Sixma JJ: The effect of thrombin on the complex between factor VIII and von Willebrand factor. Eur J Biochem 167:253, 1987
10. Koedam JA, Meijers JCM, Sixma JJ, Bouma BN: Inactivation of human factor VIII by activated protein C: Cofactor activity of protein S and protective effect of von Willebrand factor. J Clin Invest 82:1236, 1988
11. Fay PJ, Coumans J-V, Walker FJ: von Willebrand factor mediates protection of factor VIII from activated protein C-catalyzed inactivation. J Biol Chem 266:2172, 1991
12. Koppelman SJ, van Hoeij M, Lankhof H, Schiphorst ME, Damas C, Vlot AJ, Wise R, Bouma BN, Sixma JJ. Requirements of von Willebrand factor to protect factor VIII from inactivation by activated protein C. Blood 87:2292, 1996
13. Andersson L-O, Brown JE: Interaction of factor VIII-von Willebrand factor with phospholipid vesicles. Biochem J 200:161, 1981
14. Lajmonovich A, Hudry-Clergeon G, Freyssinet J-M, Marguerie G: Human factor VIII procoagulant activity and phospholipid interaction. Biochem Biophys Acta 678:123, 1981
15. Nesheim M, Pittman DD, Giles, AR, Fass DN, Wang JH, Slonosky D, Kaufman RJ: The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets. J Biol Chem 266:17815, 1991
16. Kaufman RJ, Wasley LC, Dorner AJ: Synthesis processing and secretion of factor VIII expressed in mammalian cells. J Biol Chem 263:6352, 1988
17. Wise RJ, Dorner, AJ, Krane M, Pittman, DD, Kaufman RJ: The role of von Willebrand factor multimerization and propeptide cleavage in the binding and stabilization of factor VIII. J Biol Chem 266:21948, 1991
18. Foster PA, Fulcher CA, Marti T, Titani K, Zimmerman TS: A major factor VIII binding domain resides within the amino terminal 272 amino acid residues of von Willebrand factor. J Biol Chem 262:8443, 1987
19. Bahou WH, Ginsburg D, Sikkink R, Litwiller R, Fass DN: A monoclonal antibody to von Willebrand factor (vWF) inhibits factor VIII binding. J Clin Invest 84:56, 1989
20. Takahashi Y, Kalafatis M, Girma JP, Sewerin K, Andersson LO, Meyer D: Localization of factor VIII binding domain on a 34 kilodalton fragment of the N-terminal portion of von Willebrand factor. Blood 70:1679, 1987
21. Lollar P, Hill-Eubanks DC, Parker C: Association of the factor VIII light chain with von Willebrand factor. J Biol Chem 263:10451, 1988
22. Foster PA, Fulcher CA, Houghten RA, Zimmerman TS: An immunogenic region with amino acid residues Val1670-Glu1684 of the factor VIIII light chain induces antibodies which inhibit binding of factor VIII to von Willebrand factor. J Biol Chem 263:5230, 1988
23. Saenko EL, Scandella D: The acidic region of the factor VIII light chain and the C2 domain together form the high affinity binding site for von Willebrand factor. J Biol Chem 272: 18007, 1997
24. Shima M, Scandella D, Yoshioka A, Nakai H, Tanaka I, Kamisue KS, Terada S, Fukui H: A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine. Thromb Haemost 69:240, 1993
25. Pipe AW, Kaufman RJ: Characterization of a genetically engineered inactivation-resistant coagulation factor VIIIa. Proc Natl Acad Sci USA 94:11851, 1997
26. Lollar P, Parker CG: Stoichiometry of the porcine factor VIII-von Willebrand factor association. J Biol Chem 262:17572, 1987
27. Bendetowicz AV, Morris JA, Wise RJ, Gilbert GE, Kaufman RJ: Binding of factor VIII to von Willebrand factor is enabled by cleavage of the von Willebrand factor propeptide and enhanced by formation of disulfide-linked multimers. Blood 92:529, 1998
28. Zucker MB, Soberano ME, Johnson AJ, Fulton AJ, Kowalski S, Adler M: The in vitro association of antihemophilic factor and von Willebrand factor. Thromb Haemost 49:37, 1983
29. Hamer RJ, Koedam JA, Beeser-Visser NH, Bertina RM, van Mourik JA, Sixma JJ: Factor VIII binds to von Willebrand factor via its Mr-80,000 light chain. Eur J Biochem 166:37, 1987
30. Leyte A, Verbeet MP, Brodniewicz-Proba T, Van Mourik JA, Mertens K: The interaction between human blood-coagulation factor VIII and von Willebrand factor. Biochem J 257:679, 1989
31. Vlot AJ, Koppelman SJ, van den Berg MH, Bouma BN, Sixma JJ: The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor. Blood 85:3150, 1995
32. Mannucci PM, Tenconi PA, Castaman G, Rodeghiero F: Comparison of four virus-inactivated plasma concentrates for treatment of severe von Willebrand disease: A cross-over randomized trial. Blood 79:31, 1992
33. Goudemand J, Mazurier C, Marey A, Caron C, Coupez B, Mizon P, Goudemand M: Clinical and biological evaluation in von Willebrand's disease of a von Willebrand factor concentrate with low factor VIII activity. Br J Haematol 80:214, 1992.
34. Turacek PL, Gritsch H, Pichler L, Auer W, Fischer B, Mitterer A, Mundt W, Schlokat U, Dorner F, Brinkman HJM, van Mourik JA, Schwarz HP: In vivo characterization of recombinant von Willebrand factor in dogs with von Willebrand disease. Blood 90:3555, 1997
35. Mannucci PM: Desmopressin: A nontransfusional form of treatment for cogenital and acquired bleeding disorders. Blood 72:1449, 1988
36. Bowie EJW, Owen Jr CA, Zollman PE, Thompson Jr JH, Fass DN: Tests of hemostasis in swine: Normal values and values in pigs with von Willebrand's disease. Am J Vet Res 34:1405, 1973
37. Wu Q-Y, Bahnak BR, Coulombel L, Derbiriou-Nabias D, Drouet L, Pietu G, Meulien P, Pavirani A, Caen JP, Meyer D: Analysis of von Willebrand factor mRNA from the lung of pigs with severe von Willebrand disease by using a human cDNA probe. Blood 71:1341, 1988
38. Owen Jr CA, Bowie EJW, Fass DN: Generation of factor VIII coagulant activity by isolated, perfused neonatal pig livers and adult rat livers. Br J Haematol 43:307 1979
39. Bidwell E: The purification of bovine antihemophilic globulins. Br J Haematol 1:35, 1955
40. Olson JD, Brockway WJ, Fass DN, Magnuson MA, Bowie EJW: Evaluation of ristocetin-Willebrand factor Assay and ristocetin-induced platelet aggregation. Am J Clin Path 63:210, 1975
41. Laurell C-B: Quantitative estimation of proteins by electrophoresis in agarose gel containing anatibodies. Anal Biochem 15:45, 1966
42. Toole JJ, Pittman DD, Orr EC, Murtha P, Wasley LC, Kaufman RJ: A large region (∼95 kDA) of human factor VIII is dispensable for in vitro activity. Proc Natl Acad Sci USA 83:5939, 1982
43. Hastie ND, Held W, Toole JJ: Multiple genes coding for the androgen-regulated major urinary proteins of the mouse. Cell 17:449, 1979
44. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294, 1979
45. Dorner AJ, Wasley LC, Kaufman RJ: Overexpression of GRP78 blocks stress induction of GRPs and secretion of specific proteins in Chinese hamster ovary cells. EMBO J 4:1563, 1992
46. Denhardt DT: A membrane-filter technique for the detection of complementary DNA. Biochem Biophys Res Commun 23:641, 1966
47. Olson JD, Brockway WJ, Fass DN, Bowie EJW, Mann KG: Purification of porcine and human ristocetin-Willebrand factor. J Lab Clin Med 89:1278, 1977
48. Rosendaal FR, Varekamp I, Smit C, Brocker-Vriends AHJT, van Dijck H, Vandenbroucke JP, Hermans J, Suurmeijer TPBM, Briet E: Mortality and causes of death in Dutch haemophiliacs, 1973-86. Br J Haematol 71:71, 1989
49. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR: Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345:152, 1995
50. Kelly DA, Summerfield JA, Tuddenham EGD: Localization of factor VIIIC: Antigen in guinea-pig tissues and isolated liver cell fractions. Br J Haematol 56:535, 1984
51. Zelechowska MG, van Mourik JA, Brodniewicz-Proba T: Ultrastructural localization of factor VIII procoagulant antigen in human liver hepatocytes. Nature 317:729 1985
52. Wion KL, Kelly D, Summerfield JA, Tuddenham EGD, Lawn, RM: Distribution of factor VIII mRNA and antigen in human liver and other tissues. Nature 317:726 1985
53. Kadhom N, Wolfrom C, Gautier M, Allain JP, Frommel D: Factor VIII procoagulant antigen in human tissues. Thromb Haemost 59:289, 1985
54. Marchioro TL, Hougie C, Ragde H, Epstein RB, Thomas ED: Hemophilia: Role of organ homografts. Science 163:188, 1969
55. Webster WP, Zukoski CF, Hutchin P, Reddick RL, Mandel SR, Penick GD: Plasma factor VIII synthesis and control as revealed by canine organ transplantation. Am J Physiol 220:1147, 1971
56. Lewis JH, Bontempo FA, Sperio JA, Ragni MV, Starzl TE: Liver transplantation in a Hemophiliac. N Engl J Med 312:1189, 1985
57. Bontempo FA, Lewis JH, Gorenc TJ, Spero JA, Ragni MV, Scott JP, Starzl TE: Liver transplantation in hemophilia A. Blood 69:1721, 1987
58. Groth CG, Hathaway WE, Gustafsson A, Geis WP, Putnam CW, Bjorken C, Porter KA, Starzl TE: Correction of coagulation in the hemophilic dog by transplantation of lymphatic tissue. Surgery 75:725, 1974
59. Liu L, Xia S, Seifert J: Transplantation of spleen cells in patients with hemophilia A. Transplant Int 7:210, 1994